Covered recipient · General Payments record
SONYA CHAUDHARI
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2024
$2,530.05
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,072.99 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $332.94 | 16 |
| Insulet Corporation | $268.35 | 4 |
| Lilly USA, LLC | $235.52 | 6 |
| Abbott Laboratories | $122.01 | 1 |
| Corcept Therapeutics | $114.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $122.01 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125259816 | CMS |
| Corcept Therapeutics | $114.17 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117764151 | CMS |
| Insulet Corporation | $98.50 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116798093 | CMS |
| Insulet Corporation | $150.00 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116806664 | CMS |
| Insulet Corporation | $15.13 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116798089 | CMS |
| Insulet Corporation | $4.72 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116798087 | CMS |
| Lilly USA, LLC | $32.24 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135409497 | CMS |
| Lilly USA, LLC | $34.12 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135349313 | CMS |
| Lilly USA, LLC | $12.30 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135381347 | CMS |
| Lilly USA, LLC | $125.00 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135429729 | CMS |
| Lilly USA, LLC | $23.61 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135396949 | CMS |
| Lilly USA, LLC | $8.25 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135413575 | CMS |
| Novo Nordisk Inc | $24.81 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096573514 | CMS |
| Novo Nordisk Inc | $7.51 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097146647 | CMS |
| Novo Nordisk Inc | $114.34 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097665028 | CMS |
| Novo Nordisk Inc | $17.60 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096828327 | CMS |
| Novo Nordisk Inc | $2.96 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096572216 | CMS |
| Novo Nordisk Inc | $17.03 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096789626 | CMS |
| Novo Nordisk Inc | $16.60 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097340519 | CMS |
| Novo Nordisk Inc | $15.66 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097400415 | CMS |
| Novo Nordisk Inc | $10.58 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096869757 | CMS |
| Novo Nordisk Inc | $19.61 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097815650 | CMS |
| Novo Nordisk Inc | $14.97 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096911043 | CMS |
| Novo Nordisk Inc | $7.42 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096943964 | CMS |
| Novo Nordisk Inc | $23.44 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096568878 | CMS |
| Novo Nordisk Inc | $19.47 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097505429 | CMS |
| Novo Nordisk Inc | $5.86 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097103835 | CMS |
| Novo Nordisk Inc | $15.08 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097023275 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.